Loading
Eratos Therapeutics
Eratos Therapeutics is a private, AI‑driven biotechnology company focused on central nervous system (CNS) drug discovery, with an emphasis on neurological and psychiatric disorders. Eratos Therapeutics is an early‑stage CNS‑focused biotech using AI‑powered brain‑mapping and target‑identification technology to build a pipeline of novel neurological medicines.
Funding
Every round, secondary, debt facility or acquisition involving Eratos Therapeutics that Lounge tracks, newest first.
No rounds recorded yet.
Paid members see the full deals desk — every AI round and exit, filterable by type, sector and country, with investors and reported ARR, plus CSV exports. Developer membership is $9/mo.
See plans →Log inKey numbers
—
0
—
—